rubidium has been researched along with ar-l 57 cl in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayes, JS; Kauffman, RF; Robertson, DW; Wilson, HC; Wyss, VL | 1 |
| Baker, PF; Honerjäger, P; Reiter, M | 1 |
2 other study(ies) available for rubidium and ar-l 57 cl
| Article | Year |
|---|---|
Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
Topics: Animals; Carbachol; Cats; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Female; Heart; Imidazoles; Isoproterenol; Male; Myocardial Contraction; Ouabain; Phosphodiesterase Inhibitors; Rubidium; Sodium-Potassium-Exchanging ATPase; Structure-Activity Relationship | 1986 |
Inhibition of the sodium pump in squid axons by the cardioactive drug AR-L 57.
Topics: Animals; Axons; Biological Transport, Active; Cardiotonic Agents; Decapodiformes; Imidazoles; In Vitro Techniques; Ion Exchange; Ouabain; Potassium; Rubidium; Sodium; Time Factors | 1980 |